US4181803A
(en)
|
1973-12-14 |
1980-01-01 |
Eisai Co., Ltd. |
Propiophenone derivatives and preparation thereof
|
DE3337593A1
(de)
|
1982-10-27 |
1984-05-03 |
Degussa Ag, 6000 Frankfurt |
2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
|
DE3369315D1
(en)
|
1982-10-27 |
1987-02-26 |
Degussa |
Derivatives of 2-amino-3-acylamino-6-benzylamino pyridine with an anti-epileptic activity
|
DE3665538D1
(en)
|
1985-01-23 |
1989-10-19 |
Asta Pharma Ag |
Synergistic combination of flupirtin and non-steroidal anti-phlogistics
|
DE3604575A1
(de)
|
1985-02-23 |
1986-08-28 |
Degussa Ag, 6000 Frankfurt |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
|
EP0193056B1
(de)
|
1985-02-23 |
1989-06-07 |
ASTA Pharma Aktiengesellschaft |
Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
|
JP2583067B2
(ja)
|
1987-08-04 |
1997-02-19 |
住友化学工業株式会社 |
モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
|
GB8800199D0
(en)
|
1988-01-06 |
1988-02-10 |
Beecham Group Plc |
Pharmaceutical preparation
|
MC2029A1
(fr)
|
1988-05-16 |
1990-04-25 |
Asta Pharma Ag |
(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
US6004945A
(en)
|
1990-05-10 |
1999-12-21 |
Fukunaga; Atsuo F. |
Use of adenosine compounds to relieve pain
|
IN172468B
(pl)
|
1990-07-14 |
1993-08-14 |
Asta Medica Ag |
|
US5643921A
(en)
|
1990-09-26 |
1997-07-01 |
E.R. Squibb & Sons, Inc. |
Cardiopulmonary bypass and organ transplant using a potassium channel activator
|
US5234947A
(en)
|
1991-11-07 |
1993-08-10 |
New York University |
Potassium channel activating compounds and methods of use thereof
|
DE4200259A1
(de)
|
1992-01-08 |
1993-07-15 |
Asta Medica Ag |
Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
|
US5262419A
(en)
|
1992-06-11 |
1993-11-16 |
E. R. Squibb & Sons, Inc. |
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
|
CA2115792C
(en)
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
US5428039A
(en)
|
1994-02-20 |
1995-06-27 |
The Center For Innovative Technology |
Method for electively achieving reversible hyperpolarized cardiac arrest
|
AU3162695A
(en)
|
1994-08-03 |
1996-03-04 |
Asta Medica Aktiengesellschaft |
Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
|
DE69434794T2
(de)
|
1994-09-22 |
2007-07-12 |
Smith, Richard Alan, La Jolla |
Kombination von dextromethorphan mit quinidine oder quinine sulfat zur behandlung verschiedener refraktärer störungen
|
US5679706A
(en)
|
1994-09-30 |
1997-10-21 |
Bristol-Myers Squibb Company |
Combination of a potassium channel activator and an antiarrhythmic agent
|
CA2206119C
(en)
|
1994-12-12 |
2008-05-13 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain, inflammation and spasm
|
DE19539861A1
(de)
|
1995-10-26 |
1997-04-30 |
Asta Medica Ag |
Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
|
DE19701694A1
(de)
|
1997-01-20 |
1998-07-23 |
Asta Medica Ag |
Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
|
JP2002501502A
(ja)
|
1997-04-25 |
2002-01-15 |
スミスクライン・ビーチャム・コーポレイション |
プロテアーゼ阻害物質
|
US5760007A
(en)
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
WO1999007411A1
(fr)
|
1997-08-08 |
1999-02-18 |
Chugai Seiyaku Kabushiki Kaisha |
Remedes contre les complications du diabete
|
US6265417B1
(en)
|
1997-12-18 |
2001-07-24 |
Abbott Laboratories |
Potassium channel openers
|
US6593335B1
(en)
|
1997-12-18 |
2003-07-15 |
Abbott Laboratories |
Potassium channel openers
|
US6211171B1
(en)
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
JP3441970B2
(ja)
|
1998-06-30 |
2003-09-02 |
株式会社サミー |
豆腐の製造方法及び製造装置
|
JP2000143510A
(ja)
|
1998-11-16 |
2000-05-23 |
Taisho Pharmaceut Co Ltd |
外用組成物
|
CZ20012113A3
(cs)
|
1998-12-14 |
2001-11-14 |
Cellegy Pharmaceuticals, Inc. |
Prostředky a způsoby pro léčbu onemocnění anorektální oblasti
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
GB9903476D0
(en)
|
1999-02-17 |
1999-04-07 |
Zeneca Ltd |
Therapeutic agents
|
BR0008847A
(pt)
|
1999-03-10 |
2001-12-26 |
Warner Lambert Co |
Composições analgésicas que compreendemcompostos antiepilépticos, e métodos de uso dasmesmas
|
WO2000055137A1
(en)
|
1999-03-17 |
2000-09-21 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
AT409083B
(de)
|
1999-04-01 |
2002-05-27 |
Sanochemia Pharmazeutika Ag |
Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
|
US6610324B2
(en)
|
1999-04-07 |
2003-08-26 |
The Mclean Hospital Corporation |
Flupirtine in the treatment of fibromyalgia and related conditions
|
GB9915414D0
(en)
|
1999-07-01 |
1999-09-01 |
Glaxo Group Ltd |
Medical use
|
PT1200073E
(pt)
|
1999-07-06 |
2007-03-30 |
Lilly Co Eli |
Antagonistas selectivos do receptor de iglur5 para o tratamento de enxaqueca
|
US6472165B1
(en)
|
1999-08-03 |
2002-10-29 |
Arzneimittelwerk Dresden Gmbh |
Modulatory binding site in potassium channels for screening and finding new active ingredients
|
US6495550B2
(en)
|
1999-08-04 |
2002-12-17 |
Icagen, Inc. |
Pyridine-substituted benzanilides as potassium ion channel openers
|
ATE380176T1
(de)
|
1999-08-04 |
2007-12-15 |
Icagen Inc |
Benzanilide als öffner des kaliumkanals
|
WO2001010381A2
(en)
|
1999-08-04 |
2001-02-15 |
Icagen, Inc. |
Methods for treating or preventing pain and anxiety
|
US6117900A
(en)
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
US6383511B1
(en)
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
KR100733187B1
(ko)
*
|
1999-10-26 |
2007-06-27 |
이데미쓰 고산 가부시키가이샤 |
폴리프로필렌계 필름 및 다층 적층체
|
US6538004B2
(en)
|
2000-03-03 |
2003-03-25 |
Abbott Laboratories |
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
TWI287984B
(en)
|
2000-10-17 |
2007-10-11 |
Wyeth Corp |
Pharmaceutical composition for modulating bladder function
|
US6589986B2
(en)
|
2000-12-20 |
2003-07-08 |
Wyeth |
Methods of treating anxiety disorders
|
US6469042B1
(en)
|
2001-02-20 |
2002-10-22 |
Bristol-Myers Squibb Company |
Fluoro oxindole derivatives as modulators if KCNQ potassium channels
|
AU2002338333A1
(en)
|
2001-04-04 |
2002-10-21 |
Wyeth |
Methods for treating hyperactive gastric motility
|
GB0121214D0
(en)
|
2001-08-31 |
2001-10-24 |
Btg Int Ltd |
Synthetic method
|
US6831087B2
(en)
|
2001-11-09 |
2004-12-14 |
Hoffmann-La Roche Inc. |
Pyridine substituted isoquinoline derivatives
|
AU2003202115A1
(en)
|
2002-02-12 |
2003-09-04 |
Pfizer Inc. |
Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
|
WO2003097586A1
(en)
|
2002-05-17 |
2003-11-27 |
Janssen Pharmaceutica N.V. |
Aminotetralin-derived urea modulators of vanilloid vr1 receptor
|
DE60327522D1
(de)
|
2002-05-29 |
2009-06-18 |
Hoffmann La Roche |
Bitoren der monoaminoxidase b
|
WO2003106454A1
(en)
|
2002-06-12 |
2003-12-24 |
Orchid Chemicals & Pharmaceuticals Ltd |
1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
|
AUPS312602A0
(en)
|
2002-06-21 |
2002-07-18 |
James Cook University |
Organ arrest, protection, preservation and recovery
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
WO2004047743A2
(en)
|
2002-11-22 |
2004-06-10 |
Bristol-Myers Squibb Company |
1-aryl-2-hydroxyethyl amides as potassium channel openers
|
IS7839A
(is)
*
|
2002-11-22 |
2004-05-23 |
Merck Frosst Canada Ltd. |
4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
|
DE60335028D1
(de)
|
2002-12-23 |
2010-12-30 |
Icagen Inc |
Quinazolinone als kaliumkanalmodulatoren
|
DK1578740T3
(da)
|
2002-12-27 |
2007-07-30 |
Lundbeck & Co As H |
1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
|
AU2004210149A1
(en)
|
2003-01-31 |
2004-08-19 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
AU2004220424B2
(en)
|
2003-03-14 |
2009-01-22 |
H. Lundbeck A/S |
Substituted aniline derivatives
|
AR043507A1
(es)
|
2003-03-14 |
2005-08-03 |
Lundbeck & Co As H |
Derivados de anilina sustituidos y composiciones farmaceuticas
|
EP1613303A1
(en)
|
2003-03-21 |
2006-01-11 |
H. Lundbeck A/S |
Substituted p-diaminobenzene derivatives
|
US20050014786A1
(en)
|
2003-07-11 |
2005-01-20 |
Chongqing Sun |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
EP1663239A4
(en)
|
2003-09-10 |
2008-07-23 |
Cedars Sinai Medical Center |
KALIUM CHANNEL-MEDIATED FEEDING OF MEDICINES BY THE BLOOD BRAIN BARRIER
|
US20050089559A1
(en)
|
2003-10-23 |
2005-04-28 |
Istvan Szelenyi |
Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
|
DE10359335A1
(de)
|
2003-10-23 |
2005-05-25 |
Viatris Gmbh & Co. Kg |
Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
|
CA2560346A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
RU2006139930A
(ru)
|
2004-05-03 |
2008-06-10 |
Дюк Юниверсити (Сша/Сша) (Us) |
Составы для содействия снижению веса
|
UA89503C2
(uk)
|
2004-09-13 |
2010-02-10 |
Х. Луннбек А/С |
Заміщені похідні аніліну
|
JPWO2006054513A1
(ja)
|
2004-11-19 |
2008-05-29 |
キッセイ薬品工業株式会社 |
神経因性疼痛の予防又は治療剤
|
EP1688141A1
(en)
|
2005-01-31 |
2006-08-09 |
elbion AG |
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
US7683058B2
(en)
|
2005-09-09 |
2010-03-23 |
H. Lundbeck A/S |
Substituted pyrimidine derivatives
|
JP2009256208A
(ja)
|
2006-08-17 |
2009-11-05 |
Dainippon Sumitomo Pharma Co Ltd |
フタリド誘導体またはその薬学的に許容される塩
|
JP5419691B2
(ja)
*
|
2006-08-23 |
2014-02-19 |
バレアント ファーマシューティカルズ インターナショナル |
カリウムチャネルモジュレーターとしての4−(n−アザシクロアルキル)アニリドの誘導体
|
US8367684B2
(en)
*
|
2007-06-13 |
2013-02-05 |
Valeant Pharmaceuticals International |
Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
|
US8563566B2
(en)
|
2007-08-01 |
2013-10-22 |
Valeant Pharmaceuticals International |
Naphthyridine derivatives as potassium channel modulators
|
US7786146B2
(en)
|
2007-08-13 |
2010-08-31 |
Valeant Pharmaceuticals International |
Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
|
WO2010151318A1
(en)
|
2009-06-22 |
2010-12-29 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|